Revenue: US$43.4m (down 18% from 2Q 2024). Net income: US$2.46m (down 87% from 2Q 2024). Profit margin: 5.7% (down from 35% in 2Q 2024). The decrease in margin was primarily driven by lower revenue.
© 2023 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission ...
Reports Q3 revenue $53.1M vs. $47.3M last year. “Our first earnings release as a publicly listed company marks a significant milestone for SBC Medical. After completing a successful business ...
Reports Q2 revenue $43.36M vs. $53.1M last year. Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, said, ” As anticipated and signaled in our prior guidance, Q2 2025 reflected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback